Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biochimie. 2009 Oct;91(10):1278-81. doi: 10.1016/j.biochi.2009.07.012. Epub 2009 Jul 30.

Wilson disease: current status and the future.

Author information

  • 1Division of Digestive Diseases, Adult Liver Transplant, Yale University Medical Center, New Haven, CT 06520, USA. michael.schilsky@yale.edu

Abstract

The focus of this minireview is on the current status and new advances in diagnosis and treatment of Wilson disease, an autosomal recessive disorder of copper metabolism. Molecular diagnostics have improved and complements current biochemical and clinical methods for screening for Wilson disease. Screening for Wilson disease in newborns is feasible and has been tested in limited populations, but is not yet widely performed. Identification of patients with Wilson disease as the cause of acute liver failure is possible using standard biochemical tests. Treatments for Wilson disease include chelating agents and zinc salts and liver transplantation. Future therapies may include hepatocyte transplantation and gene therapy, both of which have been tested and shown to work in animal models of Wilson disease. Future human studies await advances in these areas.

PMID:
19647032
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk